STEPHANIE DENMARK: Open Payments
NPI 1184006462 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,199 in 67 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $492 · 2025 $1,199
Food & beverage: $1,199
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $244 |
| AstraZeneca Pharmaceuticals LP | 7 | $113 |
| ABBVIE INC. | 4 | $98 |
| Lilly USA, LLC | 5 | $90 |
| Abbott Laboratories | 4 | $82 |
| PFIZER INC. | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Dexcom, Inc. | 3 | $50 |
Products named: AIRSUPRA, Rybelsus, Ozempic, FREESTYLE LIBRE 3, MOUNJARO, REXULTI, XIFAXAN, QULIPTA.
Industry payments across GA — which companies pay providers there.
